LaFleur & Godfrey’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92M | Sell |
41,443
-2,128
| -5% | -$98.5K | 0.24% | 66 |
|
|
2025
Q1 | $2.66M | Buy |
43,571
+20
| +0% | +$1.22K | 0.36% | 64 |
|
|
2024
Q4 | $2.46M | Buy |
43,551
+1,487
| +4% | +$84.1K | 0.34% | 62 |
|
|
2024
Q3 | $2.18M | Buy |
42,064
+3,222
| +8% | +$167K | 0.3% | 66 |
|
|
2024
Q2 | $1.61M | Sell |
38,842
-12,648
| -25% | -$525K | 0.24% | 69 |
|
|
2024
Q1 | $2.79M | Buy |
51,490
+9,436
| +22% | +$512K | 0.41% | 63 |
|
|
2023
Q4 | $2.16M | Sell |
42,054
-4,619
| -10% | -$237K | 0.32% | 66 |
|
|
2023
Q3 | $2.71M | Sell |
46,673
-63,855
| -58% | -$3.71M | 0.43% | 57 |
|
|
2023
Q2 | $7.07M | Buy |
110,528
+37
| +0% | +$2.37K | 1.06% | 32 |
|
|
2023
Q1 | $7.66M | Sell |
110,491
-89
| -0.1% | -$6.17K | 1.26% | 27 |
|
|
2022
Q4 | $7.96M | Sell |
110,580
-2,544
| -2% | -$183K | 1.33% | 26 |
|
|
2022
Q3 | $8.04M | Sell |
113,124
-9,114
| -7% | -$648K | 1.43% | 25 |
|
|
2022
Q2 | $9.41M | Sell |
122,238
-59,980
| -33% | -$4.62M | 1.49% | 23 |
|
|
2022
Q1 | $13.3M | Sell |
182,218
-580
| -0.3% | -$42.4K | 1.79% | 16 |
|
|
2021
Q4 | $11.4M | Buy |
182,798
+19,758
| +12% | +$1.23M | 1.46% | 23 |
|
|
2021
Q3 | $9.65M | Buy |
163,040
+14,680
| +10% | +$869K | 1.33% | 29 |
|
|
2021
Q2 | $9.91M | Buy |
148,360
+34,098
| +30% | +$2.28M | 1.42% | 25 |
|
|
2021
Q1 | $7.21M | Buy |
114,262
+18,881
| +20% | +$1.19M | 1.4% | 30 |
|
|
2020
Q4 | $5.92M | Buy |
95,381
+76,875
| +415% | +$4.77M | 1.21% | 33 |
|
|
2020
Q3 | $1.12M | Buy |
+18,506
| New | +$1.12M | 0.25% | 60 |
|
|
2016
Q1 | – | Sell |
-3,007
| Closed | -$207K | – | 72 |
|
|
2015
Q4 | $207K | Buy |
+3,007
| New | +$207K | 0.06% | 72 |
|